Long-term Outcomes after Intersphincteric Resection for Low-Lying Rectal Cancer
Norio Saito(National Cancer Center Hospital East), Masanori Sugito(National Cancer Center Hospital East), Yuji Nishizawa(National Cancer Center Hospital East), Masaaki Ito(National Cancer Centre Japan), Motohiro Kojima(Chiba Cancer Center), Akihiro Kobayashi(National Cancer Center Hospital East), Yusuke Nishizawa(National Cancer Center Hospital East)
Cited by 96
Related Papers
HD4, a 180 kDa Bullous Pemphigoid Antigen, Is a Major Transmembrane Glycoprotein of the Hemidesmosome1
|The Journal of Biochemistry|1993|145
Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212
|European Journal of Surgical Oncology|2016|138
Identification of a novel nuclear speckle‐type protein, SPOP
|FEBS Letters|1997|125
Saturated Salt Solution Method
|Medicine|2014|123
Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212)
|British journal of surgery|2020|112